Development of a malaria vaccine
- 1 December 1997
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 350 (9092) , 1696-1701
- https://doi.org/10.1016/s0140-6736(97)03256-x
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-lThe Journal of Infectious Diseases, 1996
- The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytesPublished by Elsevier ,1995
- Malarial toxins and the regulation of parasite densityParasitology Today, 1995
- Attributable fraction estimates and case definitions for malaria in endemicStatistics in Medicine, 1994
- What is the function of MSP-I on the malaria merozoite?Parasitology Today, 1994
- A malaria vaccine strategy based on the induction of cellular immunityImmunology Today, 1992
- Protection against malaria by vaccination with sporozoite surface protein 2 plus CS proteinScience, 1991
- The malaria vaccine: anti-parasite or anti-disease?Immunology Today, 1990
- Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite proteinNature, 1983
- Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesiNature, 1983